LON:OBD Oxford BioDynamics (OBD) Share Price, News & Analysis GBX 1.24 +0.01 (+0.40%) (As of 04:20 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades About Oxford BioDynamics Stock (LON:OBD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Oxford BioDynamics alerts:Sign Up Key Stats Today's Range 1.22▼ 1.3650-Day Range 1.12▼ 7.1152-Week Range 0.97▼ 38.80Volume807,402 shsAverage Volume1.82 million shsMarket Capitalization£3.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.Read More… Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Receive OBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter. Email Address OBD Stock News HeadlinesInsider Buying: Oxford BioDynamics Plc (LON:OBD) Insider Acquires 49,653 Shares of StockOctober 29 at 1:14 AM | insidertrades.comOxford BioDynamics Issues Shares to Preserve CashOctober 29 at 4:27 AM | markets.businessinsider.comEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.October 29, 2024 | Paradigm Press (Ad)Oxford BioDynamics Unveils Promising COVID Severity TestOctober 25, 2024 | markets.businessinsider.comOxford BioDynamics (LON:OBD) Stock Price Up 19.8% - Here's What HappenedOctober 23, 2024 | americanbankingnews.comOxford BioDynamics (LON:OBD) Shares Down 11.9% - Here's What HappenedOctober 22, 2024 | americanbankingnews.comLONDON MARKET CLOSE: Stocks climb as PM says UK is open for businessOctober 14, 2024 | lse.co.ukOxford BioDynamics pledges to cut costs amid need to raise extra fundsOctober 14, 2024 | lse.co.ukSee More Headlines OBD Stock Analysis - Frequently Asked Questions How have OBD shares performed this year? Oxford BioDynamics' stock was trading at GBX 28 at the start of the year. Since then, OBD shares have decreased by 95.6% and is now trading at GBX 1.24. View the best growth stocks for 2024 here. How were Oxford BioDynamics' earnings last quarter? Oxford BioDynamics Plc (LON:OBD) announced its quarterly earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share for the quarter. How do I buy shares of Oxford BioDynamics? Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Oxford BioDynamics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford BioDynamics investors own include 4D pharma (DDDD), B&M European Value Retail (BME), BP (BP), Coats Group (COA), genedrive (GDR), Greencore Group (GNC) and Intel (INTC). Company Calendar Last Earnings6/16/2020Today10/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBD CUSIPN/A CIKN/A Webwww.oxfordbiodynamics.com Phone+44-1865-518910FaxN/AEmployees45Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-11,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-266.70% Return on Assets-56.23% Debt Debt-to-Equity Ratio370.22 Current Ratio0.68 Quick Ratio2.80 Sales & Book Value Annual Sales£176,000.00 Price / Sales21.97 Cash FlowGBX 0.31 per share Price / Cash Flow3.98 Book ValueGBX 1 per share Price / Book1.24Miscellaneous Outstanding Shares311,860,000Free FloatN/AMarket Cap£3.87 million OptionableNot Optionable Beta0.42 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (LON:OBD) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.